Financhill
Buy
52

RPRX Quote, Financials, Valuation and Earnings

Last price:
$29.50
Seasonality move :
-3.63%
Day range:
$27.47 - $29.89
52-week range:
$24.05 - $31.66
Dividend yield:
2.85%
P/E ratio:
11.56x
P/S ratio:
7.76x
P/B ratio:
1.91x
Volume:
8M
Avg. volume:
3M
1-year change:
2.47%
Market cap:
$13.1B
Revenue:
$2.4B
EPS (TTM):
$2.55

Earnings Data

Next earnings date for RPRX
Feb 14
2025
Most recent earnings per share
$1.21
Beat by $0.28
(Nov 6/2024)
Consensus Estimate
$0.93
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RPRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- $1.09 --
02/14/2025 Q4 $622.4M -- -- $0.92 --
11/06/2024 Q3 $731.8M $564.7M $1.21 $0.93 $0.28
08/08/2024 Q2 $645.3M $537.3M $0.23 $0.97 -$0.74
05/09/2024 Q1 $709.4M $568M $0.01 $0.98 -$0.97
02/15/2024 Q4 $674.5M $596.1M $1.10 $1.00 $0.10
11/08/2023 Q3 -- -- $0.16 $0.77 -$0.61
08/08/2023 Q2 -- -- $0.50 $0.81 -$0.31
05/09/2023 Q1 -- -- $0.76 $1.27 -$0.51
02/15/2023 Q4 -- -- -$1.47 $1.46 -$2.93
11/08/2022 Q3 -- -- $0.32 -- --
08/04/2022 Q2 -- -- $0.70 -- --
05/05/2022 Q1 -- -- $0.12 -- --
02/15/2022 Q4 -- -- -$0.66 -- --
11/10/2021 Q3 -- -- $0.24 -- --
08/11/2021 Q2 -- -- $1.08 -- --
05/11/2021 Q1 -- -- $0.18 -- --
02/17/2021 Q4 -- -- $0.44 -- --
11/11/2020 Q3 -- -- $0.79 -- --
08/12/2020 Q2 -- -- $0.09 -- --
03/31/2020 Q1 -- -- $0.20 -- --
12/31/2019 Q4 -- -- $4.01 -- --
09/30/2019 Q3 -- -- $1.15 -- --
06/30/2019 Q2 -- -- $0.43 -- --
03/31/2019 Q1 -- -- $1.04 -- --
03/20/2017 Q4 -- -- -- -- --
11/14/2016 Q3 -- -- -- -- --
08/08/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
03/21/2016 Q4 -- -- -- -- --
11/09/2015 Q3 -- -- -- -- --
08/10/2015 Q2 -- -- -- -- --
05/11/2015 Q1 -- -- -- -- --

Royalty Pharma PLC Earnings Questions

  • How Much did Royalty Pharma PLC Generate in Revenue Last Quarter?

    Royalty Pharma PLC reported $564.7M worth of top line sales in its most recent quarter.

  • Did Royalty Pharma PLC Beat Earnings Last Quarter?

    Royalty Pharma PLC announced earnings per share of $1.21 which represents a beat of analyst forecast a $0.93 per share.

  • Is Royalty Pharma PLC Profitable?

    Royalty Pharma PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Royalty Pharma PLC EPS Next Year?

    Royalty Pharma PLC's earnings are forecast to grow from $2.53 per share to $3.95 per share next year representing an increase of 57.16%.

  • When is Royalty Pharma PLC's Earnings Date?

    Royalty Pharma PLC's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock